PTEN and cancer: While SB genetic screening studies have reported tumor suppressor genes in mouse models of cancer, these screens have often been conducted using strong oncogenic initiating mutations, including KrasG12D [10,41], BrafV600E [11,43], Apc loss [14,44], Pten loss combined with Blm loss [45], or HBV expression [31].